# Exploratory Study for Dry Mouth in Patients With Sjögren's Syndrome

> **NCT00233363** · PHASE2 · COMPLETED · sponsor: **Otsuka Pharmaceutical Co., Ltd.** · enrollment: 104 (actual)

## Conditions studied

- Xerostomia
- Sjogren's Syndrome

## Interventions

- **DRUG:** Rebamipide

## Key facts

- **NCT ID:** NCT00233363
- **Lead sponsor:** Otsuka Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-04-15
- **Primary completion:** 2006-01-19
- **Final completion:** 2006-01-27
- **Target enrollment:** 104 (ACTUAL)
- **Last updated:** 2021-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00233363

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00233363, "Exploratory Study for Dry Mouth in Patients With Sjögren's Syndrome". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00233363. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*